RS3-15742-41575 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-01
Dose 1 — Pfizer-BioNTech
2021-04-22
Dose 2 — Pfizer-BioNTech
2022-01-26
Dose 3 — Pfizer-BioNTech
2022-01-28
Registered in v-safe
2022-01-29
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2022-01-29
Report sent to call center — days 1–6 daily, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-30
Survey response — days 1–6 daily, dose 3
MedDRA: Peripheral swelling — Feeling: Poor · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Free text: Swelling of hands and feet

MedDRA releases: 2024-11 · check-in free text available
2022-01-31
Survey response — days 1–6 daily, dose 3
MedDRA: Peripheral swelling — Feeling: Fair · Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Free text: Swollen hands

MedDRA releases: 2024-11 · check-in free text available
2022-02-01
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Muscle or body aches, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Adult check-in
2022-02-01
Report sent to call center — days 1–6 daily, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-02
Health check-in — day 7, dose 3
Feeling: Fair · Muscle or body aches, Rash, not including the immediate area around the injection site

Adult check-in
2022-02-03
Call 1 — Left Voicemail
2022-02-04
Call 2 — Left Voicemail
2022-02-09
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-02-16
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-25
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2022-03-02
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-03-09
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-04-27
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-01	Pfizer-BioNTech	No
2	2021-04-22	Pfizer-BioNTech	No
3	2022-01-26	Pfizer-BioNTech	No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 11 — days 1–6 daily, dose 3

2022-01-30

Systemic reaction (other): Swelling of hands and feet

2022-01-31

Systemic reaction (other): Swollen hands

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Peripheral swelling	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release